Skip to main content
. 2023 Aug 19;14(2):854–868. doi: 10.1016/j.apsb.2023.08.014

Scheme 1.

Scheme 1

Schematic representation of the folate receptor targeting F-DPC complexes for pIL-12 and iPDL-1 delivery. Combination therapy effectively modulates the tumor microenvironment and exhibits impressive antitumor effects in ovarian cancer treatment.